Ifrah Financial Services Inc. Sells 271 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Ifrah Financial Services Inc. lessened its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 7.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 3,282 shares of the healthcare conglomerate’s stock after selling 271 shares during the period. Ifrah Financial Services Inc.’s holdings in UnitedHealth Group were worth $1,728,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in the stock. ARS Wealth Advisors Group LLC raised its stake in UnitedHealth Group by 765.4% during the fourth quarter. ARS Wealth Advisors Group LLC now owns 22,283 shares of the healthcare conglomerate’s stock worth $11,732,000 after buying an additional 19,708 shares during the last quarter. Provence Wealth Management Group lifted its stake in shares of UnitedHealth Group by 33.1% in the 4th quarter. Provence Wealth Management Group now owns 2,468 shares of the healthcare conglomerate’s stock valued at $1,299,000 after purchasing an additional 614 shares during the period. Blue Fin Capital Inc. grew its stake in UnitedHealth Group by 2.9% during the fourth quarter. Blue Fin Capital Inc. now owns 15,295 shares of the healthcare conglomerate’s stock worth $8,052,000 after purchasing an additional 434 shares during the period. VeraBank N.A. lifted its stake in UnitedHealth Group by 5.6% in the fourth quarter. VeraBank N.A. now owns 1,403 shares of the healthcare conglomerate’s stock valued at $739,000 after buying an additional 75 shares during the period. Finally, Legacy Financial Advisors Inc. lifted its position in shares of UnitedHealth Group by 5.8% during the 4th quarter. Legacy Financial Advisors Inc. now owns 5,268 shares of the healthcare conglomerate’s stock valued at $2,774,000 after acquiring an additional 290 shares during the period. 87.86% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on UNH. Cantor Fitzgerald reiterated an “overweight” rating and set a $591.00 price objective on shares of UnitedHealth Group in a report on Wednesday, April 10th. Piper Sandler raised their price objective on UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a research note on Wednesday, April 17th. Bank of America reiterated a “buy” rating and issued a $675.00 target price on shares of UnitedHealth Group in a report on Thursday, March 7th. Barclays upped their price objective on shares of UnitedHealth Group from $534.00 to $560.00 and gave the stock an “overweight” rating in a report on Wednesday, April 17th. Finally, Morgan Stanley lowered their target price on shares of UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating on the stock in a report on Friday, April 5th. Four investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $570.05.

Insider Activity at UnitedHealth Group

In other news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares in the company, valued at $4,527,306.72. The sale was disclosed in a document filed with the SEC, which is available at this link. In other news, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the sale, the executive vice president now owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by corporate insiders.

UnitedHealth Group Stock Performance

UNH traded down $0.52 during midday trading on Friday, reaching $492.45. The company had a trading volume of 2,487,811 shares, compared to its average volume of 5,130,659. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.79 and a current ratio of 0.85. The stock has a market cap of $453.09 billion, a PE ratio of 30.10, a P/E/G ratio of 1.43 and a beta of 0.55. The business has a 50-day moving average price of $482.32 and a two-hundred day moving average price of $512.76. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $554.70.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The business had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. During the same period last year, the business posted $6.26 earnings per share. The business’s revenue for the quarter was up 8.6% on a year-over-year basis. On average, sell-side analysts expect that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were issued a dividend of $1.88 per share. The ex-dividend date was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a yield of 1.53%. UnitedHealth Group’s payout ratio is 45.97%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.